| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_66c1b22707b0276e3078713a6ddcba91 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-216
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-216 |
| filingDate |
2004-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2925b12038998117990de761504e21e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b6f53aa9868f5dc5b76cd9f62533539
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55913e31a92f0bddb5bf4e0eb1c5d004 |
| publicationDate |
2005-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2546247-A1 |
| titleOfInvention |
Ppar agonists for the treatment of hcv infection |
| abstract |
The present invention concerns the use of PPAR.alpha. agonists in methods and compositions for the treatment or prevention of infection by the hepatitis C virus (HCV) in mammals, especially humans. |
| priorityDate |
2003-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |